165 related articles for article (PubMed ID: 37900425)
41. Circ-ABCB10 accelerates the malignant progression of oral squamous cell carcinoma by absorbing miRNA-145-5p.
Chen F; Li XH; Liu C; Zhang Y; Wang RJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):681-690. PubMed ID: 32016969
[TBL] [Abstract][Full Text] [Related]
42. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.
Scheepers A; Joost HG; Schürmann A
JPEN J Parenter Enteral Nutr; 2004; 28(5):364-71. PubMed ID: 15449578
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity.
Kunkel M; Moergel M; Stockinger M; Jeong JH; Fritz G; Lehr HA; Whiteside TL
Oral Oncol; 2007 Sep; 43(8):796-803. PubMed ID: 17207657
[TBL] [Abstract][Full Text] [Related]
44. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma.
Rajan C; Roshan VGD; Khan I; Manasa VG; Himal I; Kattoor J; Thomas S; Kondaiah P; Kannan S
Sci Rep; 2021 Mar; 11(1):7298. PubMed ID: 33790326
[TBL] [Abstract][Full Text] [Related]
45. Endometrial Glucose Transporters in Health and Disease.
Vrhovac Madunić I; Karin-Kujundžić V; Madunić J; Šola IM; Šerman L
Front Cell Dev Biol; 2021; 9():703671. PubMed ID: 34552924
[TBL] [Abstract][Full Text] [Related]
46. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
[TBL] [Abstract][Full Text] [Related]
47. Expression and regulation of glucose transporters in the bovine mammary gland.
Zhao FQ; Keating AF
J Dairy Sci; 2007 Jun; 90 Suppl 1():E76-86. PubMed ID: 17517754
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma.
Chang CC; Yang YJ; Li YJ; Chen ST; Lin BR; Wu TS; Lin SK; Kuo MY; Tan CT
Oral Oncol; 2013 Sep; 49(9):923-931. PubMed ID: 23602254
[TBL] [Abstract][Full Text] [Related]
49. Candida species as potential risk factors for oral squamous cell carcinoma: Systematic review and meta-analysis.
Tasso CO; Ferrisse TM; de Oliveira AB; Ribas BR; Jorge JH
Cancer Epidemiol; 2023 Oct; 86():102451. PubMed ID: 37716154
[TBL] [Abstract][Full Text] [Related]
50. The clinical implications of circulating microRNAs as potential biomarkers in screening oral squamous cell carcinoma.
Gao H; Shen Y; Feng Z; Cai Y; Yang J; Zhu Y; Peng Q
Front Oncol; 2022; 12():965357. PubMed ID: 36465364
[TBL] [Abstract][Full Text] [Related]
51. Expression of glucose transporters in human peritoneal mesothelial cells.
Schröppel B; Fischereder M; Wiese P; Segerer S; Huber S; Kretzler M; Heiss P; Sitter T; Schlöndorff D
Kidney Int; 1998 May; 53(5):1278-87. PubMed ID: 9573543
[TBL] [Abstract][Full Text] [Related]
52. Gene expression of GLUT isoforms and VHL in oral squamous cell carcinoma.
Fukuzumi M; Hamakawa H; Onishi A; Sumida T; Tanioka H
Cancer Lett; 2000 Dec; 161(2):133-40. PubMed ID: 11090961
[TBL] [Abstract][Full Text] [Related]
53. microRNA expression profiles in oral squamous cell carcinoma.
Soga D; Yoshiba S; Shiogama S; Miyazaki H; Kondo S; Shintani S
Oncol Rep; 2013 Aug; 30(2):579-83. PubMed ID: 23708842
[TBL] [Abstract][Full Text] [Related]
54. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
55. Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma.
Gintoni I; Vassiliou S; Chrousos GP; Yapijakis C
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628629
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma.
Garajei A; Parvin M; Mohammadi H; Allameh A; Hamidavi A; Sadeghi M; Emami A; Brand S
Pathogens; 2022 Feb; 11(2):. PubMed ID: 35215154
[TBL] [Abstract][Full Text] [Related]
57. Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells.
Pyla R; Poulose N; Jun JY; Segar L
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C574-89. PubMed ID: 23302780
[TBL] [Abstract][Full Text] [Related]
58. Expression of MiRNA-137 in oral squamous cell carcinoma and its clinical significance.
Sun C; Li J
J BUON; 2018; 23(1):167-172. PubMed ID: 29552778
[TBL] [Abstract][Full Text] [Related]
59. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
Shi J; Bao X; Liu Z; Zhang Z; Chen W; Xu Q
Theranostics; 2019; 9(4):920-931. PubMed ID: 30867806
[TBL] [Abstract][Full Text] [Related]
60. Clinical Diagnostic Implications of Body Fluid MiRNA in Oral Squamous Cell Carcinoma: A Meta-Analysis.
Tian X; Chen Z; Shi S; Wang X; Wang W; Li N; Wang J
Medicine (Baltimore); 2015 Sep; 94(37):e1324. PubMed ID: 26376377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
